Evidence map›Paper›PMID 38562491›Full record

ArticleHeliyon2024

Highly sensitive refractive index sensing with a dual-band optically transparent ITO-based perfect metamaterial absorber for biomedical applications.

Sumaia Jahan Mishu, Muhammad Asad Rahman, Nipa Dhar

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sumaia Jahan MishuDepartment of Electrical and Electronic Engineering, Chittagong University of Engineering and Technology, Chattogram 4349, Bangladesh.
Muhammad Asad RahmanDepartment of Electrical and Electronic Engineering, Chittagong University of Engineering and Technology, Chattogram 4349, Bangladesh.
Nipa DharDepartment of Electrical and Electronic Engineering, Chittagong University of Engineering and Technology, Chattogram 4349, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, a dual-band optically transparent square-shaped perfect metamaterial absorber operating in the frequency range from 2 to 4 terahertz (THz) is proposed. The structure consists of an indium tin oxide (ITO)-based split ring resonator (SRR) structure with additional splits and rectangular inner strips to form the top layer over the lead glass substrate. Perfect absorption is attained in the frequencies of 2.089 and 3.892 THz with absorbances of 99.99% and 99.98% in TE polarization mode, respectively. Perfect absorption is also achieved in TM polarization mode at 2.23 THz. Broadband absorption is found in TM polarization mode with full width half maximum (FWHM) of 1.1742. The proposed structure has one polarization-insensitive band in TE polarization mode. Absorbance is greater than 80% and 90% in the successive absorption peaks even at 60° and 75° of incidence, respectively. The resonance frequency is sensitive to the refractive index of the medium. As a result, the proposed metamaterial structure may be implemented as a refractive index (RI) sensor with a high sensitivity of 1109 GHz/RIU and 1954 GHz/RIU in both absorption bands for a refractive index range of 1.34 to 1.40. It's interesting to note that the refractive index of most biological samples ranges from 1.3 to 1.39. The figure of merit (FOM) of the proposed sensor can reach as high as 10 and 14 for the 1st and 2nd frequency bands. As a result, the proposed sensor has a high sensitivity and can be employed in medical applications. Potential applications of the proposed absorber include imaging, biomedical sensing, etc.

Indexed as

AbsorberDual-bandMetamaterialsRefractive index sensorSensitivity

Identifiers

PMID38562491
PMCPMC10982902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.